FI75344B - Foerfarande foer framstaellning av terapeutiskt verkande n-substituerade 2-pyridylindoler. - Google Patents
Foerfarande foer framstaellning av terapeutiskt verkande n-substituerade 2-pyridylindoler. Download PDFInfo
- Publication number
- FI75344B FI75344B FI823938A FI823938A FI75344B FI 75344 B FI75344 B FI 75344B FI 823938 A FI823938 A FI 823938A FI 823938 A FI823938 A FI 823938A FI 75344 B FI75344 B FI 75344B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- pyridyl
- methyl
- compound
- indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (4)
1. Förfarande för framställning av nya terapeutiskt ver-kande N-substituerade 2-pyridylindoler med den allmänna formeln I *2Χ\—Λ dj t II II v ' >/Y\r *3 I CHj-λ-Β i vilken formel Ri betecknar väte eller lSgalkyl, Ar beteck-nar 3- eller 4-pyridyl, R2 och R3 betecknar, oberoende av varandra, väte, lSgalkyl, halogen, hydroxi, lSgalkoxi, kar-boxilSgalkyl, lSgalkoxi-karbonyl-lSgalkyl eller lagalkyltio, 62 75344 eller R2 och R3 betecknar tillsammans, i bredvid varandra liggande kolatomer, lagalkylendioxi; Ά betecknar alkylen med 1- 12 kolatomer, alkenylen med 2-12 kolatomer, alkynylen med 2- 7 kolatomer, fenylen, en rak bindning, lagalkylen-(tio eller oxi)-lagalkylen, lagalkylen-(tio eller oxi)-fenylen eller fenylen-lagalkenylen och B är karboxi, lagalkoxikarbo-nyl, karbamoyl, mono- eller di-lägalkylkarbamoyl, hydroxime-tyl, hydroxikarbamoyl, 5-tetrazolyl eller formyl, och salter av dessa föreningar, kännetecknat därav, att 1. en förening formeln V J « 8 i vilken X betecknar väte, en alkalimetall eller tri-läg-alkylsilyl, grupperna R^, R2, R3 och Ar har den ovannämnda beteckningen, kondenseras med ett reaktionsdugligt, funktio-nelit derivat av en förening med formeln VI HO - CH2 - A - B (VI) i vilken formel grupperna A och B har den ovannämnda beteckningen, eller 2. en förening med formeln VII *2X\ «a**! L '*-N - N - i - Ar (VII) /· '
3 CH2 - A - B i vilken grupperna Ar, R^, R2, R3, A och B har den ovannämnda beteckningen, ringslutes, eller 3. en förening med formeln VIII li Ä, 75344 Ό J "Vv"* I S O (VIII), RX'VK-Ar
3 I CH2-A-B i vilken grupperna Arr Rj_, R2, R3, A och B har den ovannämn-da beteckningen, cykliseras, eller 4. i en förenincr med formeln Ia V\_/l I II II (Ia), ·. · · f i vilken grupperna A, Ar, R]_, R2 och R3 har den ovannämnda beteckningen, och väri C betecknar cyan, denna överförs i karboxi eller 5-tetrazolyl, eller väri C betecknar acetyl, denna överförs i karboxi, eller väri C betecknar halogenme-tyl, denna överförs i karboxi, eventuellt genom förlängning av kedjan A, eller väri C betecknar etinyl, denna överförs i karboxi-etinyl, varvid erhalls en förening med formeln I, i vilken B betecknar karboxi och A har förlängts tili en terminal etinylen, eller 5. en förening med formeln IX *2y\_/°» ! (! S. , (IX). /·' Y
3 CH,-A-» i vilken grupperna A, B, Ar, R2 och R3 har den ovannämnda beteckningen, dekarboxyleras, och, om sä önskas eller behövs, skyddas tillfälligt en störande reaktionsduglig grupp vid alla dessa förfaranden, och, om sl önskas, överförs en erh&llen förening med formeln I i en annan förening enligt uppfinningen, och/eller, om s! önskas, överförs en erhSllen fri förening i ett sait eller ett erhallet sait i en fri förening eller ett annat sait, och/eller, om st öns-
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32301881A | 1981-11-19 | 1981-11-19 | |
| US32301881 | 1981-11-19 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI823938A0 FI823938A0 (fi) | 1982-11-17 |
| FI823938L FI823938L (fi) | 1983-05-20 |
| FI75344B true FI75344B (fi) | 1988-02-29 |
| FI75344C FI75344C (sv) | 1988-06-09 |
Family
ID=23257445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI823938A FI75344C (sv) | 1981-11-19 | 1982-11-17 | Förfarande för framställning av terapeutiskt verkande N-substituerade 2-pyridylindoler. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0080154B1 (sv) |
| JP (1) | JPS5892677A (sv) |
| KR (1) | KR880002010B1 (sv) |
| AR (3) | AR241428A1 (sv) |
| AT (1) | ATE15196T1 (sv) |
| AU (1) | AU564233B2 (sv) |
| CA (1) | CA1197249A (sv) |
| DD (1) | DD204924A5 (sv) |
| DE (1) | DE3265892D1 (sv) |
| DK (1) | DK169104B1 (sv) |
| ES (4) | ES517439A0 (sv) |
| FI (1) | FI75344C (sv) |
| GB (1) | GB2111050B (sv) |
| GR (1) | GR77035B (sv) |
| HU (1) | HU190425B (sv) |
| IE (1) | IE54156B1 (sv) |
| IL (1) | IL67284A (sv) |
| NO (1) | NO159929C (sv) |
| NZ (1) | NZ202551A (sv) |
| PH (1) | PH19212A (sv) |
| PT (1) | PT75870B (sv) |
| ZA (1) | ZA828505B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
| GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
| US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
| US4609733A (en) * | 1984-12-27 | 1986-09-02 | Ciba-Geigy Corporation | 3-keto-substituted-N-pyridylindoles |
| GB8626296D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Therapeutic agents |
| GB8626297D0 (en) * | 1986-11-04 | 1986-12-03 | Ici Plc | Pharmaceutical compositions |
| GB9319100D0 (en) * | 1993-09-15 | 1993-11-03 | Pfizer Ltd | 3-(3-pyridinyl)h-indoles |
| CA2140722A1 (en) * | 1994-01-24 | 1995-07-25 | Joseph A. Jakubowski | Beta-carboline thromboxane synthase inhibitors |
| US6828344B1 (en) * | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| GB0307891D0 (en) * | 2003-04-04 | 2003-05-14 | Angeletti P Ist Richerche Bio | Chemical compounds,compositions and uses |
| AR072297A1 (es) * | 2008-06-27 | 2010-08-18 | Novartis Ag | Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona. |
| ES2927960T3 (es) * | 2017-12-15 | 2022-11-14 | Bristol Myers Squibb Co | Compuestos de indol éter sustituidos |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468894A (en) * | 1966-11-29 | 1969-09-23 | Geigy Chem Corp | Certain 2-pyridyl-substituted indole derivatives |
| DE2909779A1 (de) * | 1979-03-13 | 1980-09-18 | Thomae Gmbh Dr K | Neue indolderivate, deren herstellung und deren verwendung als arzneimittel |
-
1982
- 1982-11-12 GB GB08232457A patent/GB2111050B/en not_active Expired
- 1982-11-16 DE DE8282110582T patent/DE3265892D1/de not_active Expired
- 1982-11-16 EP EP82110582A patent/EP0080154B1/de not_active Expired
- 1982-11-16 AT AT82110582T patent/ATE15196T1/de active
- 1982-11-17 FI FI823938A patent/FI75344C/sv not_active IP Right Cessation
- 1982-11-17 CA CA000415716A patent/CA1197249A/en not_active Expired
- 1982-11-17 PH PH28151A patent/PH19212A/en unknown
- 1982-11-17 GR GR69837A patent/GR77035B/el unknown
- 1982-11-17 DD DD82244959A patent/DD204924A5/de not_active IP Right Cessation
- 1982-11-17 ES ES517439A patent/ES517439A0/es active Granted
- 1982-11-17 IL IL67284A patent/IL67284A/xx not_active IP Right Cessation
- 1982-11-18 NO NO823869A patent/NO159929C/no unknown
- 1982-11-18 NZ NZ202551A patent/NZ202551A/xx unknown
- 1982-11-18 HU HU823704A patent/HU190425B/hu not_active IP Right Cessation
- 1982-11-18 ZA ZA828505A patent/ZA828505B/xx unknown
- 1982-11-18 PT PT75870A patent/PT75870B/pt not_active IP Right Cessation
- 1982-11-18 IE IE2749/82A patent/IE54156B1/en not_active IP Right Cessation
- 1982-11-18 DK DK514182A patent/DK169104B1/da not_active IP Right Cessation
- 1982-11-18 AU AU90675/82A patent/AU564233B2/en not_active Ceased
- 1982-11-19 JP JP57203514A patent/JPS5892677A/ja active Granted
- 1982-11-19 KR KR8205232A patent/KR880002010B1/ko not_active IP Right Cessation
- 1982-11-19 AR AR82291366A patent/AR241428A1/es active
-
1984
- 1984-02-28 ES ES530126A patent/ES530126A0/es active Granted
- 1984-02-28 ES ES530127A patent/ES8608508A1/es not_active Expired
- 1984-02-28 ES ES530128A patent/ES8602750A1/es not_active Expired
- 1984-11-07 AR AR84298532A patent/AR243519A1/es active
- 1984-11-07 AR AR84298531A patent/AR243177A1/es active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI75344B (fi) | Foerfarande foer framstaellning av terapeutiskt verkande n-substituerade 2-pyridylindoler. | |
| US4478842A (en) | N-Substituted-2-pyridylindoles | |
| DE69705324T2 (de) | N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen | |
| US4536505A (en) | Certain N-(pyridyl) indoles | |
| US4588732A (en) | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors | |
| EP0107618B1 (en) | N-substituted-2-(1-imidazolyl)-indoles | |
| US4511573A (en) | 3-Substituted-2-(heteroaryl) indoles | |
| KR890002640B1 (ko) | 치환된 이미다조[1, 5-a]피리딘의 제조방법 | |
| US4495357A (en) | Pyridyl-substituted-benzofurans | |
| US4460777A (en) | N-Substituted-2-pyridylindoles | |
| US4539410A (en) | N-Substituted-2-(1-imidazolyl)indoles | |
| JP2939280B2 (ja) | フッ素置換メトキシキノロンカルボン酸誘導体 | |
| US4294969A (en) | Process for producing 2-bromo-3,5-disubstituted pyridines | |
| DD202572A5 (de) | Verfahren zur herstellung von neuen imidazo (1,5-a)-pyridinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NOVARTIS AG |